ID

26704

Descrizione

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Pharmacokinetics - Repeating form (Scheduled visits)

Keywords

versioni (4)
  1. 05/10/17 05/10/17 -
  2. 16/10/17 16/10/17 -
  3. 23/10/17 23/10/17 -
  4. 03/01/18 03/01/18 -
Titolare del copyright

GlaxoSmithKline

Caricato su

23 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

Inglese

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

1 moduli  
An unscheduled PK blood sample must be obtained within 72 hours of last dose
Descrizione

An unscheduled PK blood sample must be obtained within 72 hours of last dose

1. Was a pharmacokinetic blood sample obtained?
Descrizione

pharmacokinetic blood sample

Tipo di dati

boolean

If yes, date taken
Descrizione

Date of blood sample

Tipo di dati

date

If yes, time taken
Descrizione

Time of blood sample

Tipo di dati

time

If Yes, date of last investigational product dose prior to PK sample
Descrizione

date of last investigational product dose prior to PK sample

Tipo di dati

date

If Yes, time of last investigational product dose prior to PK sample
Descrizione

time of last investigational product dose prior to PK sample

Tipo di dati

time

Sample Identifier/Sample Number
Descrizione

Sample Identifier and Sample Number are conditional. The study team must choose one for inclusion on the eCRF form.

Tipo di dati

text

Ritorna all'inizio della pagina

Similar models

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
An unscheduled PK blood sample must be obtained within 72 hours of last dose
pharmacokinetic blood sample
Item
1. Was a pharmacokinetic blood sample obtained?
boolean
Date of blood sample
Item
If yes, date taken
date
Time of blood sample
Item
If yes, time taken
time
date of last investigational product dose prior to PK sample
Item
If Yes, date of last investigational product dose prior to PK sample
date
time of last investigational product dose prior to PK sample
Item
If Yes, time of last investigational product dose prior to PK sample
time
Sample Identifier/Sample Number
Item
Sample Identifier/Sample Number
text
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial